Back to Results
First PageMeta Content
Medicine / Pharmaceutical industry / Medical statistics / Nursing research / Division of Acquired Immunodeficiency Syndrome / Clinical trials / National Institute of Allergy and Infectious Diseases / Good Clinical Practice / Protocol / Research / Health / Clinical research


Policy: Requirements for Protocol Documents for DAIDS Funded and/or Sponsored Clinical Trials
Add to Reading List

Document Date: 2014-10-06 16:21:47

Open Document

File Size: 155,83 KB

Share Result on Facebook

Company

Immunodeficiency Syndrome / OPCRO Policy Group / AIDS Clinical Trial Networks / HIV/AIDS / /

Country

United States / /

/

Event

FDA Phase / Business Partnership / /

Facility

National Institute of Allergy / /

IndustryTerm

clinical trial protocol / /

MedicalCondition

AIDS / Acquired Immunodeficiency Syndrome / /

Organization

National Institute of Allergy / National Institute of Health / National Institute of Allergy and Infectious Diseases / Infectious Diseases / DAIDS Protocol Registration Office / Date Office for Policy / DAIDS V / U.S. Food and Drug Administration / /

Person

Richard Hafner / Bethesda / /

Position

Medical Officer / Director 20 DEC / RESPONSIBILITIES The Principal Investigator / /

Product

CL-01 / /

ProgrammingLanguage

C / /

Technology

clinical trial protocol / http / /

URL

http /

SocialTag